Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-07

Clinical Trial Update: Exploring the Relationship Between L-dopa Responsiveness and Small Intestinal Microbiome in Parkinson's Disease

View source ↗

Summary

University of Calgary is conducting a clinical study to examine whether levodopa response in Parkinson's disease is linked to the small intestinal microbiome. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • levodopa (levodopa)

Snippet

Sponsor: University of Calgary | Conditions: Parkinson Disease | Status: NOT_YET_RECRUITING